Toshio Morikawa

Prof. Dr. Toshio Morikawa

Pharmaceutical Research and Technology Institute, Kindai University; 3-4-1 Kowakae, Higashi-osaka, Osaka 577-8502, Japan
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2002 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
MYMasayuki Yoshikawa
Masayuki Yoshikawa
Toshio MorikawaToshio Morikawa
Toshio Morikawa
HMHisashi Matsuda
Hisashi Matsuda
GTGenzoh Tanabe
Genzoh Tanabe
OMOsamu Muraoka
Osamu Muraoka

1 April 2004 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
KNKiyofumi Ninomiya
Kiyofumi Ninomiya
HMHisashi Matsuda
Hisashi Matsuda
HSHiroshi Shimoda
Hiroshi Shimoda
NNNorihisa Nishida
Norihisa Nishida
NKNaoki Kasajima
Naoki Kasajima
MYMasayuki Yoshikawa
Masayuki Yoshikawa

1 January 2002 in Chemical and Pharmaceutical Bulletin
Verified
Journal Article
Closed access
PDF file
HMHisashi Matsuda
Hisashi Matsuda
Toshio MorikawaToshio Morikawa
Toshio Morikawa
ITIwao Toguchida
Iwao Toguchida
MYMasayuki Yoshikawa
Masayuki Yoshikawa
The methanolic extracts of several natural medicines and medicinal foodstuffs were found to show an inhibitory effect on rat lens aldose reductase. In most cases, flavonoids were isolated as the active constituents by bioassay-guided separation, and among them, quercitrin (IC50=0.15 μM), guaijaverin (0.18 μM), and desmanthin-1 (0.082 μM) exhibited potent inhibitory activity. Desmanthin-1 showed the most potent activity, which was equivalent to that of a commercial synthetic aldose reductase inhibitor, epalrestat (0.072 μM). In order to clarify the structural requirements of flavonoids for aldose reductase inhibitory activity, various flavonoids and related compounds were examined. The results suggested the following structural requirements of flavonoid: 1) the flavones and flavonols having the 7-hydroxyl and/or catechol moiety at the B ring (the 3′,4′-dihydroxyl moiety) exhibit the strong activity; 2) the 5-hydroxyl moiety does not affect the activity; 3) the 3-hydroxyl and 7-O-glucosyl moieties reduce the activity; 4) the 2–3 double bond enhances the activity; 5) the flavones and flavonols having the catechol moiety at the B ring exhibit stronger activity than those having the pyrogallol moiety (the 3′,4′,5′-trihydroxyl moiety).

1 May 2003 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
HMHisashi Matsuda
Hisashi Matsuda
Toshio MorikawaToshio Morikawa
Toshio Morikawa
SAShin Ando
Shin Ando
ITIwao Toguchida
Iwao Toguchida
MYMasayuki Yoshikawa
Masayuki Yoshikawa

1 July 2004 in Journal of Natural Products
Verified
Journal Article
Closed access
OAOsama Bashir Abdel-Halim
Osama Bashir Abdel-Halim
Toshio MorikawaToshio Morikawa
Toshio Morikawa
SAShin Ando
Shin Ando
HMHisashi Matsuda
Hisashi Matsuda
MYMasayuki Yoshikawa
Masayuki Yoshikawa

17 June 2003 in Journal of Natural Products
Verified
Journal Article
Closed access
MYMasayuki Yoshikawa
Masayuki Yoshikawa
Toshio MorikawaToshio Morikawa
Toshio Morikawa
YKYousuke Kashima
Yousuke Kashima
KNKiyofumi Ninomiya
Kiyofumi Ninomiya
HMHisashi Matsuda
Hisashi Matsuda